TAVR vs. the Least Invasive Surgically Implanted Valve

Rapid-deployment surgically implanted valves are designed to make a surgeons’ job faster and easier, compared with conventional bioprostheses, which require several stitches. These valves, which shorten surgical times, could compete with transcatheter-implanted valves (transcatheter aortic valve replacement, TAVR).

TAVI vs la válvula quirúrgica menos invasiva

The German Aortic Valve Registry analyzed 16,473 patients who underwent surgical aortic valve replacement with either a current-generation rapid-release valve or current-generation TAVR between 2011 and 2017.

Results from both procedures and devices were compared after matching patients 1:1 using propensity score.

TAVR patients were older and had higher surgical risk scores than those who underwent surgery.

Patients who underwent surgical valve replacement with rapid-release valves suffered from more disabling stroke (1.7% vs. 1.1%; p = 0.03) and needed more transfusions (8.5% vs. 1.4%; p < 0.001) and dialysis (1.9% vs. 1.2%; p = 0.01). Besides that, they had lower pacemaker implantation rates than their TAVR counterparts (8.4% vs. 14.9%; p < 0.001). 

In-hospital mortality was similar (1.6% vs. 1.8%; p = 0.62) when analyzing raw data, but after propensity score matching, a significant advantage in favor of TAVR was found (1.7% vs. 0.6%; p = 0.003).


Read also: The Best Anticoagulant Agent for AF After TAVR.


Balloon-expandable rapid-release valves had lower residual gradients than balloon-expandable TAVR. The opposite was observed with self-expanding valves, with which rapid-release valves had higher gradients.

Conclusion

This large registry of patients with aortic stenosis showed that TAVR presents an advantage in terms of in-hospital mortality compared with surgery using rapid-release valves. Rapid-release surgically implanted valves were better than percutaneous valves only in terms of pacemaker implantation.

Hemodynamic results varied according to the release mechanism of the device.

j-jcin-2020.09.018

Título original: Transcatheter Versus Rapid-Deployment Aortic Valve Replacement. A Propensity-Matched Analysis From the German Aortic Valve Registry.

Referencia: Mohamed Abdel-Wahab et al. J Am Coll Cardiol Intv 2020;13:2642–54. https://doi.org/10.1016/j.jcin.2020.09.018.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...

Is Angioplasty Always Necessary after TAVR?

Courtesy of: Silvina E. Gomez, MD The prevalence of coronary artery disease (CAD) in patients undergoing TAVR is high, ranging from 40 to 70%, according...

TAVR and Anticoagulation: What Should We Do?

Transcatheter aortic valve replacement (TAVR) has consolidated as a valid strategy for certain groups of patients. However, approximately one third of those who require...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

ROLLER COASTR-EPIC22: Comparison of Plaque Modification Techniques in Severely Calcified Coronary Lesions

The presence of coronary calcium significantly limits the success of percutaneous coronary interventions (PCI), primarily due to suboptimal stent expansion. This can lead to...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...